Denosumab for prevention of skeletal-related events in patients with bone metastases from solid tumors: incremental benefit, debatable value.

Source:http://linkedlifedata.com/resource/pubmed/id/21343550

J. Clin. Oncol. 2011 Mar 20 29 9 1095-8

Download in:

View as

General Info

PMID
21343550